Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk (B-SUPER)
Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk (B-SUPER)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
This observational or N/A phase trial investigates Breast Cancer and is currently completed. H. Lee Moffitt Cancer Center and Research Institute leads this study, which shows 13 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2024 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2022 — Apr 2024 [monthly]
Active Not Recruiting
▶ Show 8 earlier versions
-
Mar 2022 — Jun 2022 [monthly]
Active Not Recruiting
-
Jan 2022 — Mar 2022 [monthly]
Active Not Recruiting
-
Sep 2021 — Jan 2022 [monthly]
Active Not Recruiting
-
Mar 2021 — Sep 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Oct 2020 — Jan 2021 [monthly]
Recruiting
-
May 2020 — Oct 2020 [monthly]
Recruiting
-
Mar 2020 — May 2020 [monthly]
Recruiting
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- H. Lee Moffitt Cancer Center and Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .